Nectero Medical Announces Completion of $96M Series D Financing
The proceeds will support the execution of the Phase II/III trial and potential NDA submission for the Nectero EAST System, a Breakthrough Therapy for small to medium-sized AAA. April 11, 2024 05:00 AM Pacific Daylight…